HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

PD 134308

selective cholecystokinin type B receptor antagonist; inhibits growth of LoVo, a human colon cancer cell line; structure given in first source
Also Known As:
4-((2-((3-(1H-indol-3-yl)-2-methyl-1-oxo-2-(((tricyclo(3.3.1.1)-dec-2-yloxy)carbonyl)amino)propyl)amino)-1-phenethyl)amino)-4-oxobutanoate N-methyl-D-glucamine; CI 988; CI-988; PD-134308; PD134308
Networked: 25 relevant articles (2 outcomes, 10 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kim, Youngkyung: 2 articles (03/2015 - 10/2009)
2. Yoon, Young Wook: 2 articles (03/2015 - 10/2009)
3. Kim, Junesun: 2 articles (03/2015 - 10/2009)
4. Jensen, Robert T: 1 article (07/2015)
5. Moody, Terry W: 1 article (07/2015)
6. Moreno, Paola: 1 article (07/2015)
7. Nuche-Berenguer, Bernardo: 1 article (07/2015)
8. Hahm, Suk-Chan: 1 article (03/2015)
9. Cho, Hwi-young: 1 article (10/2009)
10. Hong, Seung Kil: 1 article (10/2009)

Related Diseases

1. Anxiety Disorders (Anxiety Disorder)
2. Substance-Related Disorders (Drug Abuse)
3. Pain (Aches)
4. Panic Disorder (Panic Attack)
5. Neuralgia (Stump Neuralgia)

Related Drugs and Biologics

1. Fluoxetine (Prozac)
2. RB 120
3. Cholecystokinin B Receptor
4. Cholecystokinin (Pancreozymin)
5. Morphine (MS Contin)
6. Gastrins
7. Peptoids
8. Galanin
9. Serotonin (5 Hydroxytryptamine)
10. kappa Opioid Receptors (kappa Opioid Receptor)

Related Therapies and Procedures

1. Analgesia
2. Axotomy